Homotypic Entosis as a Potential Novel Diagnostic Marker in Breast Cancer

Int J Mol Sci. 2023 Apr 6;24(7):6819. doi: 10.3390/ijms24076819.

Abstract

Homotypic entotic figures, which are a form of "cell-in-cell" structures, are considered a potential novel independent prognostic marker in various cancers. Nevertheless, the knowledge concerning the biological role of this phenomenon is still unclear. Since breast cancer cells are remarkably entosis-competent, we aimed to investigate and compare the frequency of entoses in a primary breast tumor and in its lymph node metastasis. Moreover, as there are limited data on defined molecular markers of entosis, we investigated entosis in correlation with classical breast cancer biomarkers used in routine pathomorphological diagnostics (HER2, ER, PR, and Ki67). In the study, a cohort of entosis-positive breast cancer samples paired into primary lesions and lymph node metastases was used. The inclusion criteria were a diagnosis of NOS cancer, lymph node metastases, the presence of entotic figures in the primary lesion, and/or lymph node metastases. In a selected, double-negative, HER2-positive NOS breast cancer case, entoses were characterized by a correlation between an epithelial-mesenchymal transition and proliferation markers. We observed that in the investigated cohort entotic figures were positively correlated with Ki67 and HER2, but not with ER or PR markers. Moreover, for the first time, we identified Ki67-positive mitotic inner entotic cells in clinical carcinoma samples. Our study performed on primary and secondary breast cancer specimens indicated that entotic figures, when examined by routine HE histological staining, present potential diagnostic value, since they correlate with two classical prognostic factors of breast cancer.

Keywords: HER2; Ki67; breast cancer; cell-in-cell; homotypic entosis; lymph node metastasis.

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / pathology
  • Entosis
  • Female
  • Humans
  • Ki-67 Antigen
  • Lymphatic Metastasis
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Receptors, Progesterone

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Receptors, Progesterone

Grants and funding

The research was funded by grants no. 1M15/M/MG1/N/20 and 1M15/1/M/MG/N/21, which were given to A.M.G. And by grant no. 1M15/2/M/MG/N/22/23 to P.T. The grants are supervised by I.M.-B. and are funded by a subsidy for science received by the Medical University of Warsaw.